$2 Billion to Build the Bioeconomy President Biden issued an Executive Order on Monday to create a National Biotechnology and Biomanufacturing Initiative.
Fancy French Cheese Made with Microbes Paris-based Nutropy raises $2M, Arsenal raises $220M & a biosensor for VX nerve agent.
David Baker Launches Vilya with $50 Million Vilya, a protein design company, just launched with $50M in Series A funding.
A Button, Under the Skin, Releases Insulin from Electro-Sensing Cells Electronics and computer programming have made experiments better and cells smarter.
AI-Designed Enzyme Eats Plastic A plastic-eating enzyme can break down polyethylene terephthalate (PET), the same plastic used to make water bottles and textiles, at rates that vastly exceed prior reports.
$180M for Anti-Aging Biotech & CRISPR Patent Appeal Hundreds of millions were raised for, and by, anti-aging companies. And a new protein improves mitochondrial DNA editing.
Flexible CRISPR System & Ginkgo Earnings Call A Ginkgo earnings call reveals financial packages for top executives, biotech stocks are in decline & a more flexible CRISPR system could be used to correct a wide range of disease-causing genetic variants.
Hemophilia Gene Therapy Success & Biotech Funding Surge A one-shot gene therapy for hemophilia A is superior to standard treatment, according to results from a phase 3 clinical trial.
Microbial Cocoon Helps Cells Penetrate, Shrink Tumors Synthetic biology tools, like CRISPR and protein engineering, have helped scientists to build bacteria that can travel through the body, targeting and shrinking tumors with almost pinpoint precision. A new study from researchers at Columbia University has advanced these efforts further still.
New Sequencer Reads 1 Billion Nucleotides for $5 San Diego-based Element Biosciences unveiled a commercial DNA sequencer last Monday. The device, called Aviti, could also be "adapted to study RNA, proteins, and cells," according to reporting by STAT.